Back
Akebia Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
AKBA
Akebia Therapeutics
Last Price:
1.82
Seasonality Move:
42.93%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Akebia Therapeutics Stock Forecast
-
Is Akebia Therapeutics Stock Undervalued?
The current Akebia Therapeutics [AKBA] share price is $1.79. The Score for AKBA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal. - AKBA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Akebia Therapeutics Stock Go Up Next Year?
Data Unavailable
Akebia Therapeutics Stock Rating
Data Unavailable
Akebia Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akebia.com
52-Week Data
52-Week High:
2.48
52-Week Low:
0.80
Prediction Charts
Market Cap:
390.54M
Price in USD:
1.79
Volume:
1.15M
Beta:
0.99
Technical Analysis
SMA50:
1.54
SMA100:
1.43
SMA200:
1.41
52-Wk Change:
75.49%
Stock Predictions
-
Is Akebia Therapeutics stock public?
Yes, Akebia Therapeutics is a publicly traded company. -
What is the Akebia Therapeutics stock quote today?
The Akebia Therapeutics stock price is 1.79 USD today. -
How to buy Akebia Therapeutics stock online?
You can buy Akebia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 1.70 | 1.69 | 1.75 | 1.68 |
| Nov-4 | 1.72 | 1.85 | 1.85 | 1.70 |
| Nov-5 | 1.85 | 1.86 | 1.86 | 1.78 |
| Nov-6 | 1.85 | 2.00 | 2.01 | 1.85 |
| Nov-7 | 1.74 | 1.87 | 1.91 | 1.67 |
| Nov-8 | 1.84 | 1.94 | 1.95 | 1.79 |
| Nov-11 | 1.92 | 1.99 | 2.02 | 1.90 |
| Nov-12 | 2.00 | 1.96 | 2.00 | 1.88 |
| Nov-13 | 1.95 | 1.92 | 1.98 | 1.89 |
| Nov-14 | 1.95 | 1.86 | 1.95 | 1.86 |
| Nov-15 | 1.85 | 1.79 | 1.87 | 1.76 |
| Nov-18 | 1.81 | 1.80 | 1.84 | 1.77 |
| Nov-19 | 1.79 | 1.82 | 1.82 | 1.76 |
| Nov-20 | 1.80 | 1.79 | 1.82 | 1.78 |
Akebia Therapeutics Earnings
Data Unavailable
Akebia Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.